Heart Valve Summit Video #4: “Why Are The New Transcatheter Therapies Only For Inoperable Patients?” Asks Cory
By Adam Pick on November 7, 2011
As we learned last Thursday, the FDA just approved the new SAPIEN transcatheter aortic valve replacement for inoperable patients. This exciting announcement has left many patients and caregivers wondering why the SAPIEN is only for inoperable patients in the United States.
Special Technology Update: FDA Approves First Transcatheter Aortic Valve Replacement Therapy For “Inoperable” Patients
By Adam Pick on November 3, 2011
Big, big, big, biggggggg news everybody!
By Adam Pick on October 21, 2011
I just received an email from Sharon that rekindled a memory. Sharon writes, “Hi Adam – I was recently diagnosed with severe aortic valve stenosis and I need an aortic valve replacement. Even though I’m 62 and in relatively good shape, I’m worried about making it through. Do you know what the mortality rates and surgery risks are for aortic valve replacement? Thanks, Sharon”
By Adam Pick on October 5, 2011
As patients in the United States continue to wait for FDA approval of transcatheter aortic valve replacement devices, another TAVI technology just received a CE mark for commercial use in Europe.
By Adam Pick on July 26, 2011
By Adam Pick on June 13, 2011
On the heels of the FDA approval for its Trifecta heart valve replacement, St. Jude Medical just announced that Dr. John Webb of St. Paul’s Hospital in Canada has completed the first human implant of the new Portico aortic valve replacement.
By Adam Pick on May 5, 2011
By Adam Pick on October 19, 2010
Interest in catheter-based technologies for heart valve repair and heart valve replacement continues to skyrocket.
By Adam Pick on September 11, 2010
Within minutes of posting “CoreValve Technology Get E.U. Approval”, I received two excellent questions from Jim and Mark. Their questions were, “Can the CoreValve system treat aortic regurgitation?” and “Can the CoreValve technology replace my bicuspid aortic valve?”
By Adam Pick on July 7, 2010
This is an exciting time for the medical treatment of diseased heart valves. As demonstrated in prior blogs, unique technologies are rapidly evolving to correct heart valve disorders including stenotic aortic valves and regurgitant mitral valves. That said, conversations specific to minimally invasive heart valve procedures often stimulate exciting clinical and patient possibilities.